The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.0M data for 1.3M Compounds and 9.6K Targets. Of those, 1.5M data for 695K Compounds and 4.7K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

Advanced Search

39 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Synthesis of quaternary amine ether lipids and evaluation of neoplastic cell growth inhibitory properties.EBI
University of North Carolina
Conformational analysis and molecular modeling of 1-phenyl-, 4-phenyl-, and 1-benzyl-1,2,3,4-tetrahydroisoquinolines as D1 dopamine receptor ligands.EBI
University of North Carolina
Conformational analysis, pharmacophore identification, and comparative molecular field analysis of ligands for the neuromodulatory sigma 3 receptor.EBI
University of North Carolina
ortho-Quinone tanshinones directly inhibit telomerase through an oxidative mechanism mediated by hydrogen peroxide.EBI
University of North Carolina
Nanomolar inhibition of the enterobactin biosynthesis enzyme, EntE: synthesis, substituent effects, and additivity.EBI
University of North Carolina
Structure-based alignment and comparative molecular field analysis of acetylcholinesterase inhibitors.EBI
University of North Carolina
New hexahydroxybiphenyl derivatives as inhibitors of protein kinase C.EBI
University of North Carolina
Synthesis and pharmacological evaluation of 1-phenyl-3-amino-1,2,3,4-tetrahydronaphthalenes as ligands for a novel receptor with sigma-like neuromodulatory activity.EBI
University of North Carolina
Analogues of 1,5-bis(4-amidinophenoxy)pentane (pentamidine) in the treatment of experimental Pneumocystis carinii pneumonia.EBI
University of North Carolina
Synthesis and pharmacological characterization of 1-phenyl-, 4-phenyl-, and 1-benzyl-1,2,3,4-tetrahydroisoquinolines as dopamine receptor ligands.EBI
University of North Carolina
Merging the structural motifs of functionalized amino acids and alpha-aminoamides: compounds with significant anticonvulsant activities.EBI
University of North Carolina
Insight into binding of phosphodiesterase-9A selective inhibitors by crystal structures and mutagenesis.EBI
University of North Carolina
Discovery of a 2,4-diamino-7-aminoalkoxyquinazoline as a potent and selective inhibitor of histone lysine methyltransferase G9a.EBI
University of North Carolina
Discovery and Structural Basis of the Selectivity of Potent Cyclic Peptide Inhibitors of MAGE-A4.EBI
University of North Carolina
A New Chemotype of Chemically Tractable Nonsteroidal Estrogens Based on a Thieno[2,3-EBI
University of North Carolina
Antitumor agents. Part 236: Synthesis of water-soluble colchicine derivatives.EBI
University of North Carolina
Discovery and Development of Cyclic Peptide Inhibitors of CIB1.EBI
University of North Carolina
Antitumor agents. Part 226: synthesis and cytotoxicity of 2-phenyl-4-quinolone acetic acids and their esters.EBI
University of North Carolina
Towards a RIOK2 chemical probe: cellular potency improvement of a selective 2-(acylamino)pyridine series.EBI
University of North Carolina
Antitumor Agents. 211. Fluorinated 2-phenyl-4-quinolone derivatives as antimitotic antitumor agents.EBI
University of North Carolina
Conformational analysis of D1 dopamine receptor agonists: pharmacophore assessment and receptor mapping.EBI
University of North Carolina
The structure-activity relationships of L3MBTL3 inhibitors: flexibility of the dimer interface.EBI
University of North Carolina
Synthesis and molecular modeling of 1-phenyl-1,2,3,4-tetrahydroisoquinolines and related 5,6,8,9-tetrahydro-13bH-dibenzo[a,h]quinolizines as D1 dopamine antagonists.EBI
University of North Carolina
Direct demonstration of high affinity interactions of immunosuppressant drugs with the drug binding site of the human P-glycoprotein.EBI
University of North Carolina
Disrupting antibiotic resistance propagation by inhibiting the conjugative DNA relaxase.EBI
University of North Carolina
Anti-aids agents, 6. Salaspermic acid, an anti-HIV principle from Tripterygium wilfordii, and the structure-activity correlation with its related compounds.EBI
University of North Carolina
Antitumor agents. 178. Synthesis and biological evaluation of substituted 2-aryl-1,8-naphthyridin-4(1H)-ones as antitumor agents that inhibit tubulin polymerization.EBI
University of North Carolina
Antitumor agents. 166. Synthesis and biological evaluation of 5,6,7,8-substituted-2-phenylthiochromen-4-ones.EBI
University of North Carolina
Antitumor agents. 155. Synthesis and biological evaluation of 3',6,7-substituted 2-phenyl-4-quinolones as antimicrotubule agents.EBI
University of North Carolina
Antitumor agents. 139. Synthesis and biological evaluation of thiocolchicine analogs 5,6-dihydro-6(S)-(acyloxy)- and 5,6-dihydro-6(S)-[(aroyloxy)methyl]-1,2,3-trimethoxy-9-(methylthio)-8H- cyclohepta[a]naphthalen-8-ones as novel cytotoxic and antimitotic agents.EBI
University of North Carolina
Ethyldiamine orexin receptor antagonistsBDB
Merck Sharp & Dohme
Metastin derivative and use thereofBDB
Kyoto University
Diamide compounds having muscarinic receptor antagonist and β2 adrenergic receptor agonist activityBDB
Theravance Respiratory
Design of HIV-1 protease inhibitors with pyrrolidinones and oxazolidinones as novel P1'-ligands to enhance backbone-binding interactions with protease: synthesis, biological evaluation, and protein-ligand X-ray studies.BDB
Purdue University
Discovery and SAR of 2-(1-propylpiperidin-4-yl)-1H-benzimidazole-4-carboxamide: A potent inhibitor of poly(ADP-ribose) polymerase (PARP) for the treatment of cancer.BDB
Abbott Laboratories
Pharmacological and functional comparison of the polo-like kinase family: insight into inhibitor and substrate specificity.BDB
Abbott Laboratories